A biological stabilization technology for peptide drugs: enzymatic introduction of thioether-bridges
2009
The main limitation in the application of therapeutic peptides is their rapid degradation by proteolytic enzymes. Thioether-bridges in peptides confer strong resistance against proteolytic degradation, can modulate receptor interaction and extend delivery possibilities. Their enzymatic introduction is chemo-, region- and stereo-specific and allows the stabilization of medically and economically highly important therapeutic peptides. This emerging technology has huge potential for the development of a large number of novel highly effective peptide drugs.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
33
References
10
Citations
NaN
KQI